Background: The effect of preinjury beta blockade on heart rate during initial trauma resuscitation is unclear. We hypothesized that preinjury beta blockade does not affect the heart rate response to initial trauma resuscitation. Methods: A case-control study of patients admitted to a level I trauma center was conducted. Medical records were reviewed for demographics, medications, injury information, and hemodynamic profiles. Logistic regression identified correlations between preinjury beta blockade and hemodynamics during initial trauma resuscitation and in-hospital mortality. Results: There were 76 deaths (cases) and 304 survivors (controls). Mean pre-resuscitation heart rate was 83 in patients on beta blocker and 89 in patients not on beta blocker (p ¼ 0.007). Mean post-resuscitation heart rate was 80 in patients on beta blocker and 85 in patients not on beta blocker (p ¼ 0.02). Tachycardia was present in 14.3% with preinjury beta blocker and 29.7% without (p ¼ 0.009). Bradycardia was present in 7.1% with preinjury beta blocker and 2.3% without (p ¼ 0.035). Of all patients who presented with an abnormal heart rate, 46% of patients on beta blocker attained a normal heart rate after resuscitation vs. 53% of patients not on beta blocker (p ¼ not significant). Conclusion: Preinjury beta blockade is associated with a slower presenting heart rate, more bradycardia, less tachycardia, but no difference in mortality or ability to achieve a normal heart rate with resuscitation.
Introduction
Elderly trauma patients represent a unique challenge due to higher levels of comorbidity and higher mortality. 1e3 Elderly patients account for 28% of trauma-related deaths in the United States. 4 The use of beta blocking medications is increasing in elderly patients with cardiovascular disease with approximately 7.5 million Americans currently taking beta-blockers regularly for hypertension.
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Perioperative beta blocker use has been shown to reduce morbidity and mortality in selected patients undergoing elective noncardiac surgery. 8, 9 Outcomes of trauma patients taking beta blocking medications at the time of their injury are mixed, with several studies suggesting preinjury beta blockade may lead to improved outcomes 10e12 while other studies have shown increased mortality. 13, 14 More specifically, beta-blockade may improve survival in patients with traumatic brain injury 12, 15 but worsen mortality in trauma patients without brain injury. 13, 14 The exact mechanisms for these differing outcomes remain uncertain. Beta blockade has been implicated as a cause of nonresponse in patients who fail to respond to initial trauma resuscitation. 13 However, the actual heart rate response to initial trauma resuscitation in patients with preinjury beta blockade is not documented. The purpose of this study was to determine the heart rate response to trauma and trauma resuscitation in patients taking beta blockers at the time of serious injury. We hypothesized that pre-injury beta blockade does not impair the heart rate response to initial trauma resuscitation.
Methods
This is a case-control study of patients admitted to a level I trauma center. The Institutional Review Board approved the study protocol. Information was collected from the level I trauma registry and from electronic and paper medical records. All patients admitted to the hospital between January 1, 2007 and December 31, 2010 that were over 18 years of age and met criteria for activation of the trauma system q Previous presentations: Academic Surgical Congress. Las Vegas, Nevada. Feb 14e17 2012.based on the American College of Surgeons Committee on Trauma 16 recommendations for triage were selected. Patients who were dead on arrival or died in the emergency department were excluded. Cases were all patients that met inclusion criteria and died in the hospital. Control patients were randomly selected from the pool of patients that met inclusion criteria and survived to hospital discharge. 1839 patients met selection criteria. There were 78 in hospital deaths. Two patients were excluded for incomplete information; the remaining 76 patients were included as the cases. Of the 1761 patients that survived to hospital discharge, 304 patients were randomly selected as the control patients. Information abstracted from the trauma registry included age, gender, Injury Severity Score (ISS), Glasgow Coma Scale (GCS), presence of traumatic brain injury, systolic blood pressure on arrival, emergency department length of stay, and comorbidities. The list of comorbidities included coronary artery/peripheral vascular disease, diabetes, pulmonary disease, cancer, renal failure requiring dialysis, smoking, cerebral vascular accident, and conditions requiring anticoagulation. Preadmission medications were identified by review of the computerized preadmission medication list compiled from physician and nursing admission notes and pharmacy documentation. Initial and final heart rate was abstracted from the paper chart. Tachycardia was defined as a heart rate greater than 100 beats per minute, while bradycardia was defined as a heart rate less than 60 beats per minute. The resuscitation period was defined as time from arrival in the emergency department to time of transfer out of the emergency department to the operating room, trauma intensive care unit, or surgical floor.
Unadjusted analyses were performed to compare demographic characteristics and clinical status by survivor status (dichotomized as 'survived' or 'died'). In unadjusted analyses, Pearson chi-square and Fisher exact tests were used to assess the categorical factors associated with survival or beta blocker status. Continuous variables, such as age and heart rate, were assessed with the Wilcoxon rank-sum test. Following univariate analyses, we used a multivariate logistic regression model to calculate the probability of survival in the overall cohort as well as in subgroups based on all covariates described above. All tests were considered statistically significant at a ¼ 0.05. All analyses were performed with SAS version 9.1.3 (SAS Institute, Cary, NC).
Results
380 patients were included in the study: 76 non-survivors and 304 survivors. Overall, non-survivors were older, had higher ISS, more traumatic brain injury, more cardiac and vascular disease, diabetes, and pulmonary disease. They were more likely to be on anticoagulation, and more likely to be taking a beta blocker ( Table 1) .
The percentage of patients taking a beta blocker at the time of injury was 18.4%. Survival was lower in the beta blocker group than in the non beta blocker group, 67.1% vs 82.9%, respectively (p ¼ 0.003). Patients in the beta blocker group were older, less likely to be male gender, had more traumatic brain injury, diabetes, and were more likely to be on anticoagulation than the non-beta blocker group. Patients in the beta blocker group had similar ISS and were less likely to smoke than the non-beta blocker group (Table 2) .
Overall, non-survivors and survivors had similar heart rates at presentation (87 beats per minute (bpm) vs. 88 bpm, p ¼ 0.34) and after resuscitation (84 bpm vs. 84 bpm, p ¼ 0.99). There was no difference in the incidence of tachycardia or bradycardia at presentation between the two groups. Non-survivors and survivors were equally likely to have an abnormal heart rate after resuscitation. Of the patients who presented with an abnormal heart rate, there was no difference in the likelihood of attaining a normal heart rate following resuscitation between non-survivors and survivors (58% vs 51%, respectively, p ¼ not significant) ( Table 3) .
The beta blocker group had a lower mean heart rate at admission (83 bpm vs. 89 bpm p ¼ 0.007) and after resuscitation and (80 bpm compared to 85 bpm p ¼ 0.02). There was no difference in the mean heart rate change during resuscitation between the beta blocker group and non-beta blocker group (À3.2 vs. À4.3 respectively, p ¼ 0.53). Patients in the beta blocker group had less tachycardia at presentation (14.3% vs. 29.7%, respectively, p ¼ 0.009) and more bradycardia at presentation (7.1% vs. 2.3%, respectively, p ¼ 0.035). Of the patients who presented with an abnormal heart rate, there was no difference in the likelihood of attaining a normal heart rate following resuscitation between beta blocked and non-beta blocked patients (46.7% vs. 53.3%, respectively, p ¼ not significant) ( Table 4) .
Factors associated with increased mortality in the overall population (Table 5) were age, ISS, and presence of traumatic brain injury. Use of a beta blocker, presence of abnormal heart rate at presentation, presence of abnormal heart rate after resuscitation, or presence of abnormal heart rate in the setting of beta blocker use were not associated with increased mortality. When a subset of trauma patients without head injury was analyzed, there was no difference in these findings (Table 6 ). 
Discussion
The present study shows that trauma patients taking beta blockers at the time of injury have a lower mean heart rate as well as a lower incidence of tachycardia and higher incidence of bradycardia when compared with patients not taking beta blockers. Of those patients who presented to the hospital with an abnormal heart rate, the likelihood of attaining a normal heart rate after resuscitation was nearly identical between patients on a beta blocker and those not on a beta blocker. While patients who died after being admitted to the hospital were more likely to be taking a beta blocker than those who survived, being on a beta blocker at presentation was not independently associated with mortality.
The volume of trauma involving elderly patients is increasing steadily with time. 17 Thus, it can be inferred that the number of trauma patients taking beta blockers is also increasing. In the existing literature, the effect of preinjury beta blockade on outcome in trauma patients remains uncertain.
Multiple studies have shown a potential survival advantage in trauma patients taking beta blockers. Arbabi et al. showed beta blockade to be associated with significantly lower the risk of death in a cohort of 4117 trauma patients. 10 The reduced risk was most prominent among patients with head injury. Likewise, Cotton and Inaba, in studies of 420 and 1156 patients respectively, showed beta blocker exposure to be associated with significantly reduced mortality in patients with traumatic brain injury. 12, 15 Proposed mechanisms of improved outcome with beta blockade include decreased tachycardia and myocardial oxygen demand, 18 as well as improved oxygen utilization. 19 Beta blockers have been shown to decrease circulating levels of the pro-inflammatory cytokine interleukin-6 after injury in patients at risk for heart disease. 11 The same study showed preinjury beta blockade to be associated with a less severe initial base deficit.
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Other large studies associate preinjury beta blockade with higher mortality. In a study of 1479 elderly trauma patients, beta blocker use was associated with elevated mortality in patients without head injury.
14 Likewise, in a large study of 5971 trauma patients with preexisting cardiac disease, Ferraris et al. showed beta blocker use to be associated with a relative risk of death of 2.06 (1.33e3.18). 13 It has been suggested that by blunting the stress response to shock, beta blockade may render trauma victims incapable of increasing cardiac output appropriately to maintain tissue perfusion. 14 Ferraris et al. suggest that failure of a patient to respond to normal resuscitation may be due to beta blockade, and that pressor agents such as beta-adrenergic agonists may be required to augment cardiac output in such patients. 13 To our knowledge, the present study is the only study investigating the effect of beta-blockade on heart rate during initial trauma resuscitation. While we did observe a lower mean heart rate, lower incidence of tachycardia and higher incidence of bradycardia, the heart rate response to resuscitation was similar in patients exposed and not exposed to beta blocker. Thus, an abnormal response to resuscitation in a patient on a beta blocker may be due to other factors, and use of beta-adrenergic agonists may not be beneficial. Again, while decedents were more likely to be exposed to a beta blocker than survivors, beta blocker use was not independently associated with mortality. It is possible that beta blocker use is a marker of preexisting illness and not a direct contributor to worsened outcome.
The present study has several limitations. First, we chose to perform a case-control study, and the size of the study population was limited by a relatively small number of in-hospital deaths. It is possible that a larger sample size might have revealed a small effect of beta blockade on mortality. Second, we used pulse recorded at presentation and pulse recorded before leaving the emergency department as a reflection of response to resuscitation. It is possible that additional periods of tachycardia and bradycardia occurred in the interim between presentation and discharge from the ED. Third, some patients in the study who sustained more severe injuries were likely taken for emergency surgery before a period of adequate resuscitation, while others may have experienced delays not related to management. It is thus possible that the vital signs recorded in the ED do not specifically represent the period of resuscitation. Finally, the exact measures, such as volume of crystalloid and colloid, received during the period of resuscitation in the emergency department were not investigated. More controlled studies examining the effects of beta blockade on response to acute resuscitation in trauma are needed. Further efforts should focus on the effects of beta blockade on other physiologic parameters and markers of end organ perfusion during acute trauma resuscitation, including blood pressure, pH, base deficit and urine output.
While preinjury beta blocker use is associated with lower presenting heart rate, more bradycardia, and less tachycardia, there is Table 5 Factors associated with mortality in the overall study population. no difference in heart rate response to initial trauma resuscitation. Beta blocker use was not independently associated with mortality in this study. Based on these data a failure to respond to initial trauma resuscitation should not be presumed to be the result of preinjury beta blockade and should prompt further investigation into the cause of hemodynamic instability.
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